These immune mediators are associated with the canonical Nuclear Factor Kappa B (NFκB) signaling pathway, which is persistently activated in chronic inflammatory disorders [12] and appears to be similarly dysregulated in PD [13, 14]. This evidence concerns the gene NFKB1 and Parkinson disease.